EyePoint Pharmaceuticals, Inc.·4

Mar 15, 4:21 PM ET

Pine Michael Craig 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Mar 15, 2022

Insider Transaction Report

Form 4
Period: 2022-03-14
Pine Michael Craig
Chief Corp Dev.&Strat. Officer
Transactions
  • Purchase

    Common Stock

    2022-03-14$12.21/sh+1,000$12,2101,000 total

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT